AHF: Gilead Sciences, Inc.’s "Me Too" Quad AIDS Drug Offers Little Improvement, More Kidney Damage

Published: Jul 06, 2012

LOS ANGELES--(BUSINESS WIRE)--Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.’s new four-drug HIV/AIDS pill, known as the “Quad,” renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.

Back to news